Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

Freenome plans to complete all modules of its premarket approval submission in mid-2025.

The startup received de novo authorization for the AI tool, the first of its kind that analyzes mammogram images to predict ...

Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for ...

The Trump Administration has effectively ended the Biden Administration's attempt to regulate lab-developed tests,” TD Cowen ...

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

The Court of International Trade said the president overstepped his authority, halting various duties. After an appeal, the ...

The company will compete with a device Boston Scientific acquired for $850 million.

The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.